Sign in
Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer
Journal article   Open access  Peer reviewed

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

Daniel E Spratt, Jingbin Zhang, María Santiago-Jiménez, Robert T Dess, John W Davis, Robert B Den, Adam P Dicker, Christopher J Kane, Alan Pollack, Radka Stoyanova, …
Journal of clinical oncology, Vol.36(6), pp.581-590
2018-02-20
PMCID: PMC6530900
PMID: 29185869

Abstract

Prostatic Neoplasms - pathology Prognosis Prostatic Neoplasms - genetics Genomics Humans Middle Aged Prostatic Neoplasms - classification Male Risk Aged
url
https://doi.org/10.1200/JCO.2017.74.2940View
Published (Version of record) Open

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.147 Prostate Cancer
1.147.97 Prostate Cancer
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details